ISNS:图像传感系统
1.具有成长性,
2.内部买入.成本6.5-6.8美间之间.
3.目标价:13-15美金之间.
LMNL:出卖了血浆业务。
Liminal将从出售优先审查凭证中获得最多70%的净收益,它可能有资格获得FDA对Ryplazim的批准.6.5纵然批准,含金量大打折扣,不过别...查看全文
HinvestLetter2016-08-22 18:41
报告作者:Harry Wu 报告出处:Harry's InvestLetter
相关股票:$图像传感系统(ISNS)$ $Digital Ally(DGLY)$ $美国生科ETF-iShares(IBB)$
美股投资InvestLetter Beta版,开放阅读。
网页链接查看全文
【行情】图像传感系统(ISNS.O)盘前跌幅扩大至27%,第一季度销售额同比下降5.7%。 图像传感系统(ISNS.O)盘前跌幅扩大至27%,第一季度销售额同比下降5.7%。 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000315066-12-002755 Size: 8 KB 网页链接
SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000919859-12-000023 Size: 9 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-10 AccNo: 0001128239-12-000018 Size: 7 KB 网页链接
8-K - Current report Filed: 2011-12-29 AccNo: 0000897101-11-002178 Size: 62 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits 网页链接
8-K - Current report Filed: 2011-12-20 AccNo: 0000897101-11-002140 Size: 52 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.05: Cost Associated with Exit or Disposal Activities Item 9.01: Financial Statements and Exhibits 网页链接